Minerva Surgical® Announces Acquisition Closing of Boston Scientific Intrauterine Health Products

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

Minerva Surgical announced today, the closing of the acquisition of Boston Scientific’s Intrauterine Health franchise. Minerva’s combined product line will provide healthcare practitioners with the most complete and trusted product portfolio for treating Abnormal Uterine Bleeding (AUB). According to the American College of Obstetricians and Gynecologists, about one-third of women seek treatment for heavy menstrual bleeding.1

The newly minted suite of minimally invasive tools combines the Minerva Endometrial Ablation System, the fastest growing endometrial ablation product, with the Genesys HTA™ Endometrial Ablation System, trusted for decades by physicians desiring visualization within the uterine cavity during treatment. Also included is Symphion™, the all-in-one tissue removal system that transforms the way physicians remove uterine fibroids, and the Resectr™ device for the removal of endometrial polyps.

“We are proud to have a complete product line to meet the needs of patients, whether treated in the physician’s office, ambulatory surgery center, or hospital setting,” said Eugene Skalnyi, M.D., Chief Medical Officer, Minerva Surgical. “The more effectively we treat the conditions that cause AUB, the more likely we are to achieve the objective of lowering the rate of hysterectomies for benign conditions, preserving the patient’s uterus, and positively impacting the patient’s quality of life and cost of care.”

Each year in the United States, more than 400,000 women undergo the surgical removal of their uterus. A study published in the American Journal of Obstetrics and Gynecology suggests that at least 80,000 of those hysterectomies may be unnecessary and/or could be avoided.2 Some physicians still choose to perform hysterectomies instead of safe and effective minimally invasive, organ-sparing options for the treatment of benign uterine conditions, such as fibroids and endometrial polyps.

“Minerva is now AUB’s worst nightmare,” said Dave Clapper, President & CEO, Minerva Surgical. “We are excited to do our part to eliminate this horrible condition that too often results in unnecessary hysterectomies.”

Focused exclusively on women’s uterine health, Minerva Surgical is dedicated to investments in the technological innovation and evolution of its AUB device portfolio. The goal is to stop AUB, before a hysterectomy is the only option, by providing health practitioners with a suite of the most advanced, minimally invasive treatment solutions in every setting, from the operating room to the physician office.


1 American College of Obstetricians and Gynecologists. https://www.acog.org/patient-resources/faqs/gynecologic-problems/heavy-menstrual-bleeding. Accessed April 30, 2020.
2
 American Journal of Obstetrics and Gynecology. https://www.sciencedirect.com/science/article/abs/pii/S0002937814023552. Accessed April 30, 2020.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.